Carson Wealth (CWM LLC)’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33K | Buy |
294
+13
| +5% | +$1.46K | ﹤0.01% | 3582 |
|
|
2025
Q1 | $30K | Buy |
281
+52
| +23% | +$5.55K | ﹤0.01% | 3380 |
|
|
2024
Q4 | $25K | Buy |
229
+26
| +13% | +$2.84K | ﹤0.01% | 3289 |
|
|
2024
Q3 | $20K | Buy |
203
+7
| +4% | +$690 | ﹤0.01% | 3352 |
|
|
2024
Q2 | $17K | Sell |
196
-98
| -33% | -$8.5K | ﹤0.01% | 3220 |
|
|
2024
Q1 | $21K | Sell |
294
-101
| -26% | -$7.21K | ﹤0.01% | 2874 |
|
|
2023
Q4 | $28K | Buy |
395
+4
| +1% | +$284 | ﹤0.01% | 2559 |
|
|
2023
Q3 | $23K | Buy |
391
+201
| +106% | +$11.8K | ﹤0.01% | 2602 |
|
|
2023
Q2 | $14K | Buy |
190
+7
| +4% | +$516 | ﹤0.01% | 2871 |
|
|
2023
Q1 | $13K | Buy |
183
+7
| +4% | +$497 | ﹤0.01% | 2792 |
|
|
2022
Q4 | $12K | Sell |
176
-79
| -31% | -$5.39K | ﹤0.01% | 2698 |
|
|
2022
Q3 | $14K | Hold |
255
| – | – | ﹤0.01% | 2471 |
|
|
2022
Q2 | $14K | Buy |
255
+95
| +59% | +$5.22K | ﹤0.01% | 2369 |
|
|
2022
Q1 | $11K | Sell |
160
-53
| -25% | -$3.64K | ﹤0.01% | 2419 |
|
|
2021
Q4 | $21K | Buy |
+213
| New | +$21K | ﹤0.01% | 1967 |
|
|
2019
Q1 | – | Sell |
-3
| Closed | – | – | 3104 |
|
|
2018
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 2176 |
|
|
2018
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 1690 |
|
|
2018
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 1730 |
|
|
2018
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 1482 |
|
|
2017
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 1522 |
|
|
2017
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 1521 |
|
|
2017
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 1255 |
|
|
2017
Q1 | $0 | Buy |
+3
| New | – | ﹤0.01% | 1247 |
|